Physician profile
Cheryl S Plotkin
NPI 1851388672
$1,081.76
in general payments reported to CMS, 2019-2025
21 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $212 · 2022: $208 · 2023: $171 · 2024: $250 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $661.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $205.64 | 2022-2025 | |
| Daiichi Sankyo INC. | $118.43 | 2022-2025 | Datroway, Enhertu |
| Janssen Biotech, INC. | $90.88 | 2022-2025 | Darzalex, Talvey, Tecvayli |
| Genzyme Corporation | $89.96 | 2021-2023 | |
| Astellas Pharma US INC | $73.41 | 2021-2025 | Veozah, Padcev |
| Merck Sharp & Dohme LLC | $55.82 | 2023-2025 | Keytruda |
| Taiho Oncology, INC. | $53.08 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $52.20 | 2021 | |
| Genentech USA, INC. | $46.59 | 2022-2023 | Polivy |
| Astrazeneca Pharmaceuticals Lp | $43.95 | 2023-2025 | Enhertu, Calquence |
| Pfizer INC. | $38.38 | 2021-2022 | |
| Abbvie INC. | $36.52 | 2021-2023 | |
| Seagen INC. | $33.08 | 2022 | |
| Exelixis INC. | $28.86 | 2025 | Cabometyx |
| Mirati Therapeutics, INC. | $28.82 | 2023-2024 | Krazati |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $16.31 | 2022 | |
| Aveo Pharmaceuticals, INC. | $15.20 | 2025 | |
| Hologic Sales and Service, LLC | $15.12 | 2023 | Biozorb |
| Eisai INC. | $13.94 | 2025 | |
| Incyte Corporation | $12.93 | 2021 | |
| Alexion Pharmaceuticals, INC. | $12.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Plotkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.